Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Cancer Chemotherapy and Pharmacology
|
September 22, 2006
Urinary excretion of L-carnitine and its short-chain acetyl-L-carnitine in patients undergoing carboplatin treatment
Angelo Mancinelli, S D'Iddio, R Bisonni, et al.
The Journal of the Oklahoma State Medical Association
|
March 1, 1993
Human ehrlichiosis--an overview
S L Silberg, R Bisonni, D E Parker, et al.
Minerva Medica
|
October 19, 2000
Advanced non-small cell lung cancer in the elderly: effective and well tolerated weekly gemcitabine and cisplatin regimen. A pilot study
P Lippe, R R Silva, L Giuliodori, et al.
British Journal of Cancer
|
June 27, 2002
Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients
F Graziano, R Bisonni, V Catalano, et al.
Anticancer Research
|
October 30, 2004
Long-survival in responding patients with metastatic breast cancer treated with doxorubicin-docetaxel combination. A multicentre phase II trial
R Mattioli, P Lippe, C Massacesi, et al.
British Journal of Cancer
|
March 5, 2009
Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy
V Catalano, F Loupakis, F Graziano, et al.
British Journal of Cancer
|
August 30, 2008
Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy
F Graziano, A Ruzzo, F Loupakis, et al.
The Pharmacogenomics Journal
|
December 24, 2008
Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer
F Graziano, A Ruzzo, E Canestrari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 3, 2011
Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer
V Catalano, F Loupakis, F Graziano, et al.
The Pharmacogenomics Journal
|
June 6, 2007
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy
A Ruzzo, F Graziano, F Loupakis, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Cancer Chemotherapy and Pharmacology
|
September 22, 2006
Urinary excretion of L-carnitine and its short-chain acetyl-L-carnitine in patients undergoing carboplatin treatment
Angelo Mancinelli, S D'Iddio, R Bisonni, et al.
The Journal of the Oklahoma State Medical Association
|
March 1, 1993
Human ehrlichiosis--an overview
S L Silberg, R Bisonni, D E Parker, et al.
Minerva Medica
|
October 19, 2000
Advanced non-small cell lung cancer in the elderly: effective and well tolerated weekly gemcitabine and cisplatin regimen. A pilot study
P Lippe, R R Silva, L Giuliodori, et al.
British Journal of Cancer
|
June 27, 2002
Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients
F Graziano, R Bisonni, V Catalano, et al.
Anticancer Research
|
October 30, 2004
Long-survival in responding patients with metastatic breast cancer treated with doxorubicin-docetaxel combination. A multicentre phase II trial
R Mattioli, P Lippe, C Massacesi, et al.
British Journal of Cancer
|
March 5, 2009
Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy
V Catalano, F Loupakis, F Graziano, et al.
British Journal of Cancer
|
August 30, 2008
Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy
F Graziano, A Ruzzo, F Loupakis, et al.
The Pharmacogenomics Journal
|
December 24, 2008
Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer
F Graziano, A Ruzzo, E Canestrari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 3, 2011
Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer
V Catalano, F Loupakis, F Graziano, et al.
The Pharmacogenomics Journal
|
June 6, 2007
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy
A Ruzzo, F Graziano, F Loupakis, et al.
Page
of 1